Fast-rising girl group KATSEYE is going on its first tour, which includes a stop in San Francisco. The tour sold out within ...
Foodie Bethany Gaskin highlights a Jollibee family feast mukbang featuring Filipino favorites. Steelers linked to Aaron Rodgers replacement ahead of NFL trade deadline Trump Says ‘We’re Gone’ If Milei ...
President Trump announced that an agreement has been reached to end the war in Gaza — hours after his Secretary of State handed him a note during a White House event. He may travel to Egypt soon. Some ...
President Trump announced Wednesday a ceasefire has been reached between Israel and Hamas, paving the way for the release of 20 living hostages and relief for nearly 2 million Palestinians in the Gaza ...
Roundhill Investments has resurrected an exchange-traded fund focused on holding a basket of so-called meme stocks nearly two years after shutting down the original. The Roundhill Meme Stock ETF MEME ...
T-Mobile will reportedly retire its 4G LTE network. Mobile phone users should have a gradual transition. The news comes as T-Mobile is promoting T-Satellite with Starlink. As one service grows, 4G ...
AstraZeneca has hailed another phase 3 win for its blood pressure drug candidate baxdrostat, boosting its attempts to turn the molecule’s long half-life into a competitive advantage. Baxdrostat, an ...
Skye Bioscience’s obesity candidate has failed to reduce weight in a phase 2 study, marking another setback for the CB1 inhibitor class. The biotech had been evaluating a 200-mg weekly subcutaneous ...
– After 14 days of treatment in healthy volunteers, ARV-102 decreased lysosomal and neuroinflammatory microglial pathway biomarkers known to be elevated in Parkinson’s disease – NEW HAVEN, Conn., Oct.
What has been going down on the University of Nebraska Medical Center campus in Omaha soon will start to go up. Project Health, the new $2.19 billion academic medical center planned on the University ...
The biggest stories of the day delivered to your inbox.
Dosing has successfully commenced with healthy volunteers Primary endpoints for the Phase 1 trial include safety, tolerability, and pharmacokinetic (PK) profile of the combination Topline data are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results